Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cornblath, D. R.
Right arrow Articles by McArthur, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cornblath, D. R.
Right arrow Articles by McArthur, J. C.
NEUROLOGY 1988;38:794
© 1988 American Academy of Neurology

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

David R. Cornblath, MD and Justin C. McArthur, MB, BS

From the Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.

The most common type of peripheral neuropathy associated with human immunodeficiency virus (HIV) infection, predominantly sensory neuropathy, affects 10–30% of patients with acquired immunodeficiency syndrome (AIDS). From 40 individuals with peripheral neuropathy and HIV infection, we have identified 26 patients with this syndrome. All had constitutional symptoms when neuropathic symptoms developed; 20 had AIDS and six had AIDS-related complex. The most common complaint was pain on the soles. Paresthesias were frequent and usually involved the entire foot. Signs of peripheral neuropathy were present in all; the most frequent finding was absent or reduced ankle reflexes. Electrophysiologic studies revealed abnormal sensory and motor conduction, studies suggesting a dying-back axonopathy. Over time, the neuropathy progressed in all except one patient with ARC, who had spontaneous subjective improvement. Tricyclic antidepressants provided partial symptomatic relief. In three patients, the neuropathy did not change during azidothymidine treatment. Predominantly sensory neuropathy in HIV infection appears to be a distal axonal degeneration primarily involving sensory neurons. The mechanism is unknown, but the neuropathy is associated with the late manifestations of HIV infection.

Address correspondence and reprint requests to Dr. Cornblath, Meyer 2–147, 600 N. Wolfe St., Baltimore, MD 21205.

Supported by NIH grant NS23539 and contract A132520 and the NIH-funded GCRC 5M01RR00722 and 5M01RR00035.

Received July 15, 1987. Accepted for publication in final form September 21, 1987.




This article has been cited by other articles:


Home page
BrainHome page
G. J. Ebenezer, J. C. McArthur, D. Thomas, B. Murinson, P. Hauer, M. Polydefkis, and J. W. Griffin
Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies
Brain, October 1, 2007; 130(10): 2703 - 2714.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. N. Herrmann, M. P. McDermott, J. E. Sowden, D. Henderson, S. Messing, K. Cruttenden, and G. Schifitto
Is skin biopsy a predictor of transition to symptomatic HIV neuropathy?: A longitudinal study
Neurology, March 28, 2006; 66(6): 857 - 861.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. L. Cherry, R. L. Skolasky, L. Lal, J. Creighton, P. Hauer, S. P. Raman, R. Moore, K. Carter, D. Thomas, G. J. Ebenezer, et al.
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort
Neurology, March 28, 2006; 66(6): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Zhu, G. Jones, S. Tsutsui, W. Opii, S. Liu, C. Silva, D. A. Butterfield, and C. Power
Lentivirus Infection Causes Neuroinflammation and Neuronal Injury in Dorsal Root Ganglia: Pathogenic Effects of STAT-1 and Inducible Nitric Oxide Synthase
J. Immunol., July 15, 2005; 175(2): 1118 - 1126.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Schifitto, M. P. McDermott, J. C. McArthur, K. Marder, N. Sacktor, D. R. McClernon, K. Conant, B. Cohen, L. G. Epstein, K. Kieburtz, et al.
Markers of immune activation and viral load in HIV-associated sensory neuropathy
Neurology, March 8, 2005; 64(5): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. R. Watters, P. W. Poff, B. T. Shiramizu, P. S. Holck, K. M.S. Fast, C. M. Shikuma, and V. G. Valcour
Symptomatic distal sensory polyneuropathy in HIV after age 50
Neurology, April 27, 2004; 62(8): 1378 - 1383.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
S. Evans, B. Fishman, L. Spielman, and A. Haley
Randomized Trial of Cognitive Behavior Therapy Versus Supportive Psychotherapy for HIV-Related Peripheral Neuropathic Pain
Psychosomatics, February 1, 2003; 44(1): 44 - 50.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Schifitto, M. P. McDermott, J. C. McArthur, K. Marder, N. Sacktor, L. Epstein, K. Kieburtz, and the Dana Consortium on the Therapy of HIV Dementia
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy
Neurology, June 25, 2002; 58(12): 1764 - 1768.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Schifitto, C. Yiannoutsos, D. M. Simpson, B. T. Adornato, E. J. Singer, H. Hollander, C. M. Marra, M. Rubin, B. A. Cohen, T. Tucker, et al.
Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy
Neurology, October 9, 2001; 57(7): 1313 - 1316.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. P. d. Q. C. Araújo, O. J. M. Nascimento, and O. S. Garcia
Distal Sensory Polyneuropathy in a Cohort of HIV-Infected Children Over Five Years of Age
Pediatrics, September 1, 2000; 106(3): 35e - 35.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
G. Schifitto, M. P. McDermott, T. Evans, T. Fitzgerald, J. Schwimmer, L. Demeter, and K. Kieburtz
Autonomic Performance and Dehydroepiandrosterone Sulfate Levels in HIV-1-Infected Individuals: Relationship to TH1 and TH2 Cytokine Profile
Arch Neurol, July 1, 2000; 57(7): 1027 - 1032.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Martin, G. Solders, A. Sonnerborg, and P. Hansson
Antiretroviral therapy may improve sensory function in HIV-infected patients: A pilot study
Neurology, June 13, 2000; 54(11): 2120 - 2127.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. C. McArthur, C. Yiannoutsos, D. M. Simpson, B. T. Adornato, E. J. Singer, H. Hollander, C. Marra, M. Rubin, B. A. Cohen, T. Tucker, et al.
A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
Neurology, March 14, 2000; 54(5): 1080 - 1088.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. R. Berger, H. H. Schaumburg, M. N. Gourevitch, K. Freeman, S. Herskovitz, and J. C. Arezzo
Prevalence of peripheral neuropathy in injection drug users
Neurology, August 1, 1999; 53(3): 592 - 592.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Cui, L. Locatelli, M.-Y. Xie, and J.-P. Sommadossi
Effect of Nucleoside Analogs on Neurite Regeneration and Mitochondrial DNA Synthesis in PC-12 Cells
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1228 - 1234.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by AAN Enterprises, Inc.